Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (67)
Filtered (67)
Filter

Filter

67 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(67) Reset
Show (67)
Cancel
Apply(67) Reset
67 entriesShowing 61–67
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Adrenocorticolytic agents · Dogs · During Chemotherapy · New Diagnosis

Mitotane in Canine Adrenal Disease and Adrenocortical Tumours

mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Ribonucleotide-reductase inhibitors · Dogs & Cats · During Chemotherapy · New Diagnosis

Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile

hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Methylhydrazine antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile

procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile

paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile

docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and CardioprotectionRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Anthracycline protective agents · Dogs & Cats · During Chemotherapy · Limited / Emerging Evidence · Veterinary Clinical Use

Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and Cardioprotection

dexrazoxane is covered as emergency extravasation antidote and selected anthracycline cardioprotectant, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Awake cat monitored by a veterinary oncology team with a closed infusion systemRepresentative category illustration – not the named product or a real patient.
Chemotherapy · Prescription Drug · CMOP feline lymphoma protocol · Cats · During Chemotherapy · New Diagnosis · Limited / Emerging Evidence

Feline CMOP for Intermediate- to Large-Cell Lymphoma

cyclophosphamide, mitoxantrone, vincristine and prednisolone is covered as multi-agent feline lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more